ClinConnect ClinConnect Logo

Main Menu

Search for Trials
For HCPs
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up
Search / Trial NCT00440258

Cabergoline Reduces OHSS

Launched by INSTITUTO VALENCIANO DE INFERTILIDAD, IVI VALENCIA · Feb 23, 2007

Download PDF Apply for Trial

Trial Information

Current as of April 25, 2025

Completed

Keywords

Ovarian Hyperstimulation Syndrome, Dopamine Agonists, Cabergoline, Hemoconcentration, Ascites, Ovarian Perfusion, Dopamine Receptor 2

ClinConnect Summary

Patients and Study design This study was performed in 82 oocyte donors between April 2004 and July 2006. The study protocol was approved by our institution's Ethical Committee and all participants signed a written consent form. The protocol for COH has previously been described (23). Only patients at risk of developing OHSS were included. The definition of risk was the development of 20-30 follicles \>12 mm in diameter, and retrieval of \>20 oocytes. Once the decision to administer hCG was taken, patients were immediately allocated into two groups based on a computer randomization: the stud...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • • 18 - 35 years old healthy women, with risk of developing OHSS.
  • Exclusion Criteria:
  • • No risk of developing OHSS; \< 20 oocytes retrieved.

Trial Officials

Antonio Pellicer, MD

Study Director

IVI VALENCIA

About Instituto Valenciano De Infertilidad, Ivi Valencia

Instituto Valenciano de Infertilidad (IVI Valencia) is a leading fertility clinic and research institution dedicated to advancing reproductive health and assisted reproductive technologies. With a commitment to providing personalized care and innovative treatment options, IVI Valencia conducts clinical trials aimed at enhancing the understanding and effectiveness of infertility therapies. The institute combines state-of-the-art facilities with a team of experienced specialists, ensuring high standards of patient safety and ethical research practices. IVI Valencia plays a pivotal role in fostering scientific advancements in the field of reproductive medicine, ultimately striving to improve outcomes for individuals and couples facing fertility challenges.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials